Sugi Predict

Sugi Predict / Compounds / SCHEMBL18372160

SCHEMBL18372160

SCHEMBL18372160

O=P(c1ccc(-c2ccc3c4ccc(-c5ccc(P(=O)(c6ccc7oc8ccccc8c7c6)c6ccc7oc8ccccc8c7c6)cc5)cc4c4ccccc4c3c2)cc1)(c1ccc2oc3ccccc3c2c1)c1ccc2oc3ccccc3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.43
▸ PLA2G4A P47712 5/20 0.43
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CASP3 P42574 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ AHR P35869 2/20 0.39
▸ PLA2G10 O15496 1/20 0.39
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16440753 0.94 PLA2G2A (0.43) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL16440658 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL16440646 0.93 PLA2G2A (0.48) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL18372037 0.92 MAPT (0.49) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL16440829 0.89 PLA2G2A (0.50) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL16440675 0.89 PLA2G2A (0.50) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL21123029 0.89 AHR (0.41) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL21123044 0.88 MEN1 (0.45) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL24470251 0.88 PLA2G2A (0.45) PLA2G2APLA2G4AMAPTMEN1KMT2A
SCHEMBL9927330 0.87 MAPT (0.53) PLA2G2APLA2G4AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-02-19 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE PIEZO1, TERT, TPR PLA2G2A 4416/4885PLA2G4A 4608/4885MAPT 1255/4885
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device PIEZO1, TERT, TPR PLA2G2A 4416/4885PLA2G4A 4608/4885MAPT 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.